UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood-based biomarkers

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2016, Vol.3 (1), p.51-62

2016

Volltextzugriff (PDF)

Early Detection of Alzheimer's Disease-Related Pathology Using a Multi-Disease Diagnostic Platform Employing Autoantibodies as Blood-Based Biomarkers

Journal of Alzheimer's disease, 2023-01, Vol.92 (3), p.1077-1091

2023

Volltextzugriff (PDF)

Evidence that Brain-Reactive Autoantibodies Contribute to Chronic Neuronal Internalization of Exogenous Amyloid-β1-42 and Key Cell Surface Proteins During Alzheimer's Disease Pathogenesis

Journal of Alzheimer's disease, 2020, Vol.74 (1), p.345-361

2020

Volltextzugriff (PDF)

Serum Autoantibodies as Biomarkers for Parkinsons Disease: Background and Utility

AIMS medical science, 2015-01, Vol.2 (4), p.316-327

2015

Volltextzugriff (PDF)

Potential utility of autoantibodies as blood-based biomarkers for early detection and diagnosis of Parkinson’s disease

Immunology letters, 2015-11, Vol.168 (1), p.80-88

2015

Volltextzugriff (PDF)

APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer's disease: a systematic review

Alzheimer's research & therapy, 2020-11, Vol.12 (1), p.141-141, Article 141

2020

Volltextzugriff (PDF)

Diagnosis of Alzheimer's disease based on disease-specific autoantibody profiles in human sera

PloS one, 2011-08, Vol.6 (8), p.e23112-e23112

2011

Volltextzugriff (PDF)

Natural IgG autoantibodies are abundant and ubiquitous in human sera, and their number is influenced by age, gender, and disease

PloS one, 2013-04, Vol.8 (4), p.e60726-e60726

2013

Volltextzugriff (PDF)

Diagnosis of Parkinson's disease based on disease-specific autoantibody profiles in human sera

PloS one, 2012-02, Vol.7 (2), p.e32383-e32383

2012

Volltextzugriff (PDF)

Sevoflurane and Isoflurane induce structural changes in brain vascular endothelial cells and increase blood−brain barrier permeability: Possible link to postoperative delirium and cognitive decline

Brain research, 2015-09, Vol.1620, p.29-41

2015

Volltextzugriff (PDF)

Detection of early-stage Alzheimer's pathology using blood-based autoantibody biomarkers in elderly hip fracture repair patients

PloS one, 2019-11, Vol.14 (11), p.e0225178-e0225178

2019

Volltextzugriff (PDF)

Diabetes and hypercholesterolemia increase blood-brain barrier permeability and brain amyloid deposition: beneficial effects of the LpPLA2 inhibitor darapladib

Journal of Alzheimer's disease, 2013-01, Vol.35 (1), p.179-198

2013

Volltextzugriff (PDF)

Association Between Neuropsychiatric Symptoms and Blood‐Based Autoantibody Biomarkers

Alzheimer's & dementia, 2022-12, Vol.18 (S5), p.n/a

2022

Volltextzugriff (PDF)

Preclinical Detection and Monitoring of Alzheimer’s Disease Using a Multi‐Disease Diagnostic Platform Employing Autoantibodies as Blood‐based Biomarkers

Alzheimer's & dementia, 2022-12, Vol.18 (S5), p.n/a

2022

Volltextzugriff (PDF)

[P3–215]: UTILITY OF DISEASE‐LINKED DEPLETION OF AUTOANTIBODIES AS BIOMARKERS FOR EARLY, BLOOD‐BASED DETECTION AND MONITORING OF ALZHEIMER's AND OTHER NEURODEGENERATIVE DISEASES

Alzheimer's & dementia, 2017-07, Vol.13 (7S_Part_21), p.P1019-P1020

2017

Volltextzugriff (PDF)

The origin and nature of the complex autoantibody profile in cerebrospinal fluid

Brain, behavior, & immunity. Health, 2020-02, Vol.2, p.100032-100032, Article 100032

2020

Volltextzugriff (PDF)

Autoantibodies as diagnostic biomarkers for the detection and subtyping of multiple sclerosis

Journal of neuroimmunology, 2017-08, Vol.309, p.51-57

2017

Volltextzugriff (PDF)

DETECTION OF PRECLINICAL AND PRODROMAL ALZHEIMER’S DISEASE USING A MULTIDISEASE DIAGNOSTIC PLATFORM

Innovation in aging, 2022-12, Vol.6 (Supplement_1), p.589-589

2022

Volltextzugriff (PDF)

S12. THE ‘AUTOANTIBODYOME’ IN PSYCHOSIS: A PILOT STUDY AND BLUEPRINT FOR BIOMARKER DISCOVERY

Schizophrenia bulletin, 2018-04, Vol.44 (suppl_1), p.S328-S328

2018

Volltextzugriff (PDF)

Utility of autoantibodies as biomarkers for diagnosis and staging of neurodegenerative diseases

International review of neurobiology, 2015, Vol.122, p.1-51

2015

Volltextzugriff (PDF)

Neuronal PAD4 expression and protein citrullination: Possible role in production of autoantibodies associated with neurodegenerative disease

Journal of autoimmunity, 2012-06, Vol.38 (4), p.369-380

2012

Volltextzugriff (PDF)

P4‐317: Detection of Alzheimer’S Disease at Mild Cognitive Impairment and Disease Staging Using Autoantibodies as Blood‐Based Biomarkers

Alzheimer's & dementia, 2016-07, Vol.12 (7S_Part_24), p.P1155-P1156

2016

Volltextzugriff (PDF)

DETECTION OF ALZHEIMER’S DISEASE AT MILD COGNITIVE IMPAIRMENT AND DISEASE STAGING USING AUTOANTIBODIES AS BLOOD-BASED BIOMARKERS

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P1155-P1156

2016

Volltextzugriff (PDF)

P4‐235: Diagnosis of early‐stage Alzheimer's disease at mild cognitive impairment using autoantibodies as blood‐based biomarkers

Alzheimer's & dementia, 2015-07, Vol.11 (7S_Part_19), p.P870-P870

2015

Volltextzugriff (PDF)

Diagnosis of early-stage Alzheimer’s disease at mild cognitive impairment using autoantibodies as blood-based biomarkers

Alzheimer's & dementia, 2015-07, Vol.11 (7), p.P870-P870

2015

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood-based biomarkers

Early Detection of Alzheimer's Disease-Related Pathology Using a Multi-Disease Diagnostic Platform Employing Autoantibodies as Blood-Based Biomarkers

Evidence that Brain-Reactive Autoantibodies Contribute to Chronic Neuronal Internalization of Exogenous Amyloid-β1-42 and Key Cell Surface Proteins During Alzheimer's Disease Pathogenesis

Serum Autoantibodies as Biomarkers for Parkinsons Disease: Background and Utility

Potential utility of autoantibodies as blood-based biomarkers for early detection and diagnosis of Parkinson’s disease

APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer's disease: a systematic review

Diagnosis of Alzheimer's disease based on disease-specific autoantibody profiles in human sera

Natural IgG autoantibodies are abundant and ubiquitous in human sera, and their number is influenced by age, gender, and disease

Diagnosis of Parkinson's disease based on disease-specific autoantibody profiles in human sera

Sevoflurane and Isoflurane induce structural changes in brain vascular endothelial cells and increase blood−brain barrier permeability: Possible link to postoperative delirium and cognitive decline

Detection of early-stage Alzheimer's pathology using blood-based autoantibody biomarkers in elderly hip fracture repair patients

Diabetes and hypercholesterolemia increase blood-brain barrier permeability and brain amyloid deposition: beneficial effects of the LpPLA2 inhibitor darapladib

Association Between Neuropsychiatric Symptoms and Blood‐Based Autoantibody Biomarkers

Preclinical Detection and Monitoring of Alzheimer’s Disease Using a Multi‐Disease Diagnostic Platform Employing Autoantibodies as Blood‐based Biomarkers

[P3–215]: UTILITY OF DISEASE‐LINKED DEPLETION OF AUTOANTIBODIES AS BIOMARKERS FOR EARLY, BLOOD‐BASED DETECTION AND MONITORING OF ALZHEIMER's AND OTHER NEURODEGENERATIVE DISEASES

The origin and nature of the complex autoantibody profile in cerebrospinal fluid

Autoantibodies as diagnostic biomarkers for the detection and subtyping of multiple sclerosis

DETECTION OF PRECLINICAL AND PRODROMAL ALZHEIMER’S DISEASE USING A MULTIDISEASE DIAGNOSTIC PLATFORM

S12. THE ‘AUTOANTIBODYOME’ IN PSYCHOSIS: A PILOT STUDY AND BLUEPRINT FOR BIOMARKER DISCOVERY

Utility of autoantibodies as biomarkers for diagnosis and staging of neurodegenerative diseases

Neuronal PAD4 expression and protein citrullination: Possible role in production of autoantibodies associated with neurodegenerative disease

P4‐317: Detection of Alzheimer’S Disease at Mild Cognitive Impairment and Disease Staging Using Autoantibodies as Blood‐Based Biomarkers

DETECTION OF ALZHEIMER’S DISEASE AT MILD COGNITIVE IMPAIRMENT AND DISEASE STAGING USING AUTOANTIBODIES AS BLOOD-BASED BIOMARKERS

P4‐235: Diagnosis of early‐stage Alzheimer's disease at mild cognitive impairment using autoantibodies as blood‐based biomarkers

Diagnosis of early-stage Alzheimer’s disease at mild cognitive impairment using autoantibodies as blood-based biomarkers

Suchergebnisse filtern